Home > Site Help > Search Results

07-35398-01 600953 Prelude Therapeutics Incorporated

Accession Number: ML17263B139

Date Released: Wednesday, November 15, 2017

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML17300B100 - Prelude Therapeutics Incorporated; Telephone Conversation Record dated 10/24/17 Subject: RAI, New Facility Description. (1 page(s), 10/24/2017)
• ML17306A633 - Prelude Therapeutics Incorporated, e-mail dated October 27, 2017, Subject Deficiency Response. (2 page(s), 10/27/2017)
• ML17310A169 - Prelude Therapeutics Incorporated, Cover Letter dtd October 30, 2017, for License Amendment No. 1, Control No. 600953. (3 page(s), 10/30/2017)
• ML17310A172 - Prelude Therapeutics Incorporated, License Amendment No. 1, Control No. 600953. (2 page(s), 10/30/2017)